Atomwise patented the first deep learning technology for structure-based small molecule drug discovery. This AI technology harnesses millions of data points and thousands of protein structures to solve problems that a human chemist would take many lifetimes to solve. They've partnered with some of the world’s largest pharmaceutical and agrochemical companies, and with more than 50 leading academic institutions and hospitals, to tackle the challenges of discovering and developing better drugs and chemicals. 

Biotechnology

Atomwise

Gavin Hirst

Wenhu Huang

Matthew Merkley

Mallorie Lynch

Ed Kawashiri

Robert Mittendorff

Izhar Wallach

Denzil Bernard

Yan Zhao

Nicole Dishotsky

Drug Discovery and Medicinal Chemistry

Leadership Team

Directors Team

Engineering Team

Scientific Research Team

Product and Project Management

Teams at Atomwise